【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Dementia
06.2 Epidemiology & Forecast (2013-2018)
06.3 Types of Dementia
07. Alzheimer’s Disease
07.1 A Global Burden
07.2 Etiology
07.3 Cost of Care
07.4 Alzheimer’s Disease & Caregiving
08. Market Landscape
08.1 Market Overview
08.2 Market Size and Forecast
08.3 Five Forces Analysis
09. Market Segmentation by MOA
09.1.1 AChE Inhibitors
09.1.2 Glutamate Inhibitors
10. Market Assessment of Top Drugs
10.1 Aricept
10.1.1 Sales
10.1.2 Key Regulatory Approvals and Agreements
10.1.3 US Spending by Various Channels 2010-2013
10.2 Exelon
10.2.1 Sales
10.2.2 Key Regulatory Approvals and Agreements
10.2.3 US Spending by Various Channels 2010-2013
10.3 Namenda
10.3.1 Sales
10.3.2 Key Regulatory Approvals and Agreements
10.3.3 US Spending by Various Channels 2010-2013
10.4 Radazyne
10.4.1 Sales
10.4.2 Key Regulatory Approvals and Agreements
11. Competitive Assessment of Top Drugs
12. Focus on Alzheimer’s Research
12.1 National Alzheimer’s Project Act
12.2 Clinical Pipeline
13. Geographical Segmentation
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.2 Market Share Analysis 2013
22. Future Vendors Expected To Tap the Market
23. Key Vendor Analysis
23.1 Eisai Co., Ltd.
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Sales by Geography
23.1.4 Revenue Comparison
23.1.5 Sales by Geography
23.1.6 Business Strategy
23.1.7 Key Information
23.1.8 SWOT Analysis
23.1.9 Strengths
23.1.10 Weaknesses
23.1.11 Opportunities
23.1.12 Threats
23.2 Forest Laboratories Inc.
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business/Product Segmentation
23.2.4 Product Segmentation by Revenue 2013
23.2.5 Business/Products Segmentation by Revenue 2012 and 2013
23.2.6 Sales by Geography
23.2.7 Business Strategy
23.2.8 Key Information
23.2.9 SWOT Analysis
23.2.10 Strengths
23.2.11 Weaknesses
23.2.12 Opportunities
23.2.13 Threats
23.3 Janssen Pharmaceuticals Inc.
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Product Segmentation
23.3.4 Business Strategy
23.3.5 Key Information
23.3.6 SWOT Analysis
23.3.7 Strengths
23.3.8 Weaknesses
23.3.9 Opportunities
23.3.10 Threats
23.4 Novartis AG
23.4.1 Key Facts
23.4.2 Business Description
23.4.3 Business Segmentation
23.4.4 Revenue by Business Segmentation
23.4.5 Revenue Comparison 2012 and 2013
23.4.6 Sales by Geography
23.4.7 Business Strategy
23.4.8 Key Developments
23.4.9 SWOT Analysis
23.4.10 Strengths
23.4.11 Weaknesses
23.4.12 Opportunities
23.4.13 Threats
24. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Projected Prevalence of Dementia by Regions 2013-2050 (in millions)
Exhibit 3: Projected Prevalence of Dementia by Regions 2013-2018 (in millions)
Exhibit 4: Types of Dementia by Prevalence 2013
Exhibit 5: Alzheimer’s Disease and Other Dementias Burden by Geographical Segmentation (Annually) 2013
Exhibit 6: Costs of Care by Payer for Americans Age 65 and Older with Alzheimer‘s Disease and Other Dementias 2013
Exhibit 7: Distribution of Alzheimer’s Caregivers by Age, 2013
Exhibit 8: Projected Prevalence of dependence in 2030 (in percent)
Exhibit 9: Global Alzheimer’s Disease Drugs Market 2013-2018 (US$ billion)
Exhibit 10: Global Alzheimer’s Drugs Market Segmentation by MOA
Exhibit 11: Eisai Co. Ltd.’s Aricept Revenue FY1996-FY2013 (US$ million)
Exhibit 12: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY1996-FY2010 (US$ million)
Exhibit 13: Eisai Co. Ltd.’s Aricept Geography-wise Revenue FY2011-FY2013 (US$ million)
Exhibit 14: Key Event Timeline of Aricept Formulations
Exhibit 15: Timeline for Aricept Formulations in US and Europe
Exhibit 16: US Spending on Aricept by Various Channels 2010-2013
Exhibit 17: Novartis AG’s Exelon Revenue 2001-2013 (US$ million)
Exhibit 18: Novartis AG’s Exelon Geography-Wise Revenue 2001-2013 (US$ million)
Exhibit 19: Key Event Timeline of Exelon Formulations
Exhibit 20: US Spending on Exelon by Various Channels 2010-2013
Exhibit 21: Forest’s Namenda Revenue 2004-2014 (FY ending March 2014) (US$ million)
Exhibit 22: Key Event Timeline of Namenda Formulations
Exhibit 23: US Spending on Namenda by Various Channels 2010-2013
Exhibit 24: Razadyne Revenue 2007-2009 (US$ million)
Exhibit 25: Key Event Timeline of Razadyne
Exhibit 26: Sales of Top 3 Alzheimer’s Drugs FY 2004-2013 (US$ million)
Exhibit 27: Sales of Top 3 Alzheimer’s Drugs 2004-2013 (US$ million)
Exhibit 28: Alzheimer’s Disease Research Projects by NIH Institutes and Centers 2011
Exhibit 29: NIH funded Alzheimer’s Disease Research Projects by CADRO topic 2011
Exhibit 30: Classification of Disease Modifying Pipeline Molecules by MOA
Exhibit 31: Clinical Trials of Alzheimer’s Disease by Phase 2013
Exhibit 32: Clinical Trials of Alzheimer’s Disease by Recruitment Status 2013
Exhibit 33: Promising Late Stage Pipeline Molecules 2013
Exhibit 34: Global Alzheimer’s Drugs market by Geographical Segmentation 2013
Exhibit 35: 65+ Global Population 2014-2018 (in million)
Exhibit 36: Global Alzheimer’s Drugs Market Share Analysis 2013
Exhibit 37: Eisai Co., Ltd.: Geographical Segmentation of Revenue for 2013 and 2012(US$ billion)
Exhibit 38: Eisai Co., Ltd.: Revenue comparison for the last 3 years (US$ billion)
Exhibit 39: Eisai Co., Ltd.: Sales by Geography for 2013 (US$ billion)
Exhibit 40: Forest Laboratories Inc.: Product Segmentation (by therapeutic areas) 2013
Exhibit 41: Forest Laboratories Inc.: Product Segmentation by Revenue 2013
Exhibit 42: Forest Laboratories Inc.: Product Segmentation by Revenue 2012 and 2013(US$ million)
Exhibit 43: Company Name: Sales by Geography 2013
Exhibit 44: Janssen Pharmaceuticals, Inc.: Product Segmentation 2013
Exhibit 45: Novartis AG: Business Segmentation
Exhibit 46: Novartis AG: Revenue by Business Segmentation 2013
Exhibit 47: Novartis AG: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 48: Novartis AG: Revenue by Geographical Segmentation 2013
【レポート販売概要】
■ タイトル：アルツハイマー治療薬のグローバル市場（2014-2018）■ 英文：Global Alzheimer's Drugs Market 2014-2018
■ 発行日：2014年6月20日
■ 調査会社：Technavio
■ 商品コード：IRTNTR3675
■ 調査対象地域：グローバル
- 世界の風疹検査市場The report presents a detailed analysis of the Rubella diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Rubella definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerc …
- 世界の高度道路交通システム（ITS）市場（2014-2018）About Intelligent Transport Systems Intelligent transport systems are sophisticated applications that provide solutions for various modes of transport and traffic management. They allow commuters to be informed, safe, and save traveling time, as well as reduce the cost and increase the quality of the traffic management process. These systems are used for multiple applications, especially by govern …
- ウェット型(新生血管型/滲出型)黄斑変性症の治療薬パイプライン動向（2015年上半期版）Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015’, provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Wet (Neovascular / Exud …
- 滑り止めセラミックタイルの世界市場ABSTRACTAbout Anti-Skid Ceramic Tiles Anti-skid ceramic tiles are slip-resistant tiles that find applications in kitchens, bathrooms, ramps, courtyards, balcony, swimming pools, public wet areas such as public washrooms, showers, and changing rooms. Technavio’s analysts forecast the global anti-skid ceramic tiles market to grow at a CAGR of 11.7% during the period 2017-2021. [Covered in this repor …
- 外科手術用ステープリングデバイスの世界市場：最終用途別（病院、外来センター）、製品別（電動、手動）、種類別（再使用可能、使い捨て）、セグメント予測The global surgical stapling devices market size is anticipated to reach USD 8.02 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.23% during the forecast period. Application of surgical staplers has gradually evolved from invasive surgeries to minimally invasive surgeries. With introduction of advanced surgical staplers, difficulties associated w …
- 家族/屋内エンターテイメントセンターの中東市場Family/indoor entertainment centers (FEC) are miniature indoor/outdoor amusement parks marketed toward families with small children to teenagers, and often are entirely indoors or associated with a larger operation such as a theme park. It offers a wide variety of entertainment activities for all age groups. FECs usually cater to sub-regional markets of larger metropolitan areas and are generally …
- 世界のウエアラブル技術市場：フィットネス、mヘルス、拡張現実、カメラ、e-テキスタイルWearable technology is the buzzword of 2014. A market that has existed for decades, the supporting technologies and public interest are finally sufficient for it to flourish. In an environment heading towards a connected homes paradigm, the next step in our technological evolution is bringing control closer than arm’s reach. Wearables dominated 2014’s CES, with many major OEMs moving into their se …
- アイウェアの世界市場：コンタクトレンズ、サングラス、メガネAbout Eyewear Eyewear enhances vision and corrects eye defects such as myopia, presbyopia, and astigmatism. Eye defects are widely prevalent and demand for corrective eyewear is on the rise.It is also used for protecting the eyes from sunlight or dust, as well as for aesthetic appeal. Eyewear can be categorized as prescription eyewear, non-prescription eyewear, and others. Technological advancemen …
- グローバルにおけるHDTV市場（2014-2018）About HDTV The HDTV is a next generation television equipped with better resolution and high quality display. It is based on a digital broadcasting format that transmits a widescreen display, enlarged and clear image, better sound quality and projections. According to the EIA, high definition in TV can be measured by the resolution of the picture or the number of horizontal and vertical lines scan …
- シリコンフォトニクスの世界市場：光導波路、光変調器、光検出器、WDM（波長分割多重）、レーザ、トランシーバー、アクティブ光ケーブル、マルチプレクサ、減衰器The silicon photonics market is expected to be worth USD 1,078.9 Million by 2022, at a CAGR of 22.1% between 2016 and 2022. This technology is widely used in the data communication and telecommunication applications. It is one of the emerging technologies perceived as a long-term strategic solution for the high-speed data transfer, using optical rays to transfer the data between different computer …
- 冷凍・冷蔵物流サービスの世界市場The refrigerated transport market is projected to grow at a CAGR of 15.2% from 2014 to 2019, and poised to exhibit a strong growth in the next five years. Globalization and its associated growth in international trade of perishables have led to the development of several new markets for the import and export of temperature-sensitive goods such as vegetables, fruits, dairy, meat, fish, and seafood …
- 世界のエピクロルヒドリン市場The increasing demand of Epichlorohydrin in China and growth in the end-user segments such as paint and electronic industry are key factors to drive the global ECH market. Epoxy resin is the main application which consumes a large part of Epichlorohydrin. Properties of epoxy resin make it suitable for wide variety of applications such as paints, electrical & electronics, construction, wind turbine …
- Chronic Plaque Psoriasis：グローバル臨床試験レビューH2, 2013Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Chronic Plaque Psoriasis Global Clinical Trials Review, H2, 2013" provides data on the Chronic Plaque Psoriasis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Plaque Psoriasis. It includes an overview of the trial num …
- Royal Dutch Shell plc：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- 世界の皮膚適用薬市場動向（2014-2018）TechNavio's analysts forecast the Global Dermatological Drugs market to grow at a CAGR of 4.29 percent over the period 2013-2018. One of the key factors contributing to this market’s growth is an increase in the aging population worldwide. The Global Dermatological Drugs market has also been witnessing a spurt in the use of biologics. However, the risk of adverse side effects associated with derma …
